List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Neurodegenerative Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurodegenerative Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurodegenerative Disease Overall Market Size
2.1 Global Neurodegenerative Disease Market Size: 2023 VS 2030
2.2 Global Neurodegenerative Disease Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neurodegenerative Disease Players in Global Market
3.2 Top Global Neurodegenerative Disease Companies Ranked by Revenue
3.3 Global Neurodegenerative Disease Revenue by Companies
3.4 Top 3 and Top 5 Neurodegenerative Disease Companies in Global Market, by Revenue in 2023
3.5 Global Companies Neurodegenerative Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurodegenerative Disease Players in Global Market
3.6.1 List of Global Tier 1 Neurodegenerative Disease Companies
3.6.2 List of Global Tier 2 and Tier 3 Neurodegenerative Disease Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neurodegenerative Disease Market Size Markets, 2023 & 2030
4.1.2 NMDA
4.1.3 SSRIs
4.1.4 Dopamine Inhibitors
4.2 By Type - Global Neurodegenerative Disease Revenue & Forecasts
4.2.1 By Type - Global Neurodegenerative Disease Revenue, 2019-2024
4.2.2 By Type - Global Neurodegenerative Disease Revenue, 2025-2030
4.2.3 By Type - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurodegenerative Disease Market Size, 2023 & 2030
5.1.2 Parkinson?s Disease
5.1.3 Huntington Disease
5.1.4 Amyotrophic Lateral Sclerosis
5.1.5 Alzheimer?s Disease
5.2 By Application - Global Neurodegenerative Disease Revenue & Forecasts
5.2.1 By Application - Global Neurodegenerative Disease Revenue, 2019-2024
5.2.2 By Application - Global Neurodegenerative Disease Revenue, 2025-2030
5.2.3 By Application - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Neurodegenerative Disease Market Size, 2023 & 2030
6.2 By Region - Global Neurodegenerative Disease Revenue & Forecasts
6.2.1 By Region - Global Neurodegenerative Disease Revenue, 2019-2024
6.2.2 By Region - Global Neurodegenerative Disease Revenue, 2025-2030
6.2.3 By Region - Global Neurodegenerative Disease Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Neurodegenerative Disease Revenue, 2019-2030
6.3.2 US Neurodegenerative Disease Market Size, 2019-2030
6.3.3 Canada Neurodegenerative Disease Market Size, 2019-2030
6.3.4 Mexico Neurodegenerative Disease Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Neurodegenerative Disease Revenue, 2019-2030
6.4.2 Germany Neurodegenerative Disease Market Size, 2019-2030
6.4.3 France Neurodegenerative Disease Market Size, 2019-2030
6.4.4 U.K. Neurodegenerative Disease Market Size, 2019-2030
6.4.5 Italy Neurodegenerative Disease Market Size, 2019-2030
6.4.6 Russia Neurodegenerative Disease Market Size, 2019-2030
6.4.7 Nordic Countries Neurodegenerative Disease Market Size, 2019-2030
6.4.8 Benelux Neurodegenerative Disease Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Neurodegenerative Disease Revenue, 2019-2030
6.5.2 China Neurodegenerative Disease Market Size, 2019-2030
6.5.3 Japan Neurodegenerative Disease Market Size, 2019-2030
6.5.4 South Korea Neurodegenerative Disease Market Size, 2019-2030
6.5.5 Southeast Asia Neurodegenerative Disease Market Size, 2019-2030
6.5.6 India Neurodegenerative Disease Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Neurodegenerative Disease Revenue, 2019-2030
6.6.2 Brazil Neurodegenerative Disease Market Size, 2019-2030
6.6.3 Argentina Neurodegenerative Disease Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neurodegenerative Disease Revenue, 2019-2030
6.7.2 Turkey Neurodegenerative Disease Market Size, 2019-2030
6.7.3 Israel Neurodegenerative Disease Market Size, 2019-2030
6.7.4 Saudi Arabia Neurodegenerative Disease Market Size, 2019-2030
6.7.5 UAE Neurodegenerative Disease Market Size, 2019-2030
7 Neurodegenerative Disease Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Neurodegenerative Disease Major Product Offerings
7.1.4 Novartis Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Neurodegenerative Disease Major Product Offerings
7.2.4 Pfizer Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.2.5 Pfizer Key News & Latest Developments
7.3 Merck Serono
7.3.1 Merck Serono Company Summary
7.3.2 Merck Serono Business Overview
7.3.3 Merck Serono Neurodegenerative Disease Major Product Offerings
7.3.4 Merck Serono Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.3.5 Merck Serono Key News & Latest Developments
7.4 Biogen Idec
7.4.1 Biogen Idec Company Summary
7.4.2 Biogen Idec Business Overview
7.4.3 Biogen Idec Neurodegenerative Disease Major Product Offerings
7.4.4 Biogen Idec Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.4.5 Biogen Idec Key News & Latest Developments
7.5 TEVA
7.5.1 TEVA Company Summary
7.5.2 TEVA Business Overview
7.5.3 TEVA Neurodegenerative Disease Major Product Offerings
7.5.4 TEVA Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.5.5 TEVA Key News & Latest Developments
7.6 UCB
7.6.1 UCB Company Summary
7.6.2 UCB Business Overview
7.6.3 UCB Neurodegenerative Disease Major Product Offerings
7.6.4 UCB Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.6.5 UCB Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Neurodegenerative Disease Major Product Offerings
7.7.4 Boehringer Ingelheim Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Neurodegenerative Disease Major Product Offerings
7.8.4 Sanofi Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.8.5 Sanofi Key News & Latest Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Summary
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Neurodegenerative Disease Major Product Offerings
7.9.4 GlaxoSmithKline Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.9.5 GlaxoSmithKline Key News & Latest Developments
7.10 Livzon Pharmaceutical
7.10.1 Livzon Pharmaceutical Company Summary
7.10.2 Livzon Pharmaceutical Business Overview
7.10.3 Livzon Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.10.4 Livzon Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.10.5 Livzon Pharmaceutical Key News & Latest Developments
7.11 Haisco Pharmaceutical
7.11.1 Haisco Pharmaceutical Company Summary
7.11.2 Haisco Pharmaceutical Business Overview
7.11.3 Haisco Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.11.4 Haisco Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.11.5 Haisco Pharmaceutical Key News & Latest Developments
7.12 Jingxin Pharmaceutical
7.12.1 Jingxin Pharmaceutical Company Summary
7.12.2 Jingxin Pharmaceutical Business Overview
7.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.12.4 Jingxin Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.12.5 Jingxin Pharmaceutical Key News & Latest Developments
7.13 Dongcheng Biochemicals
7.13.1 Dongcheng Biochemicals Company Summary
7.13.2 Dongcheng Biochemicals Business Overview
7.13.3 Dongcheng Biochemicals Neurodegenerative Disease Major Product Offerings
7.13.4 Dongcheng Biochemicals Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.13.5 Dongcheng Biochemicals Key News & Latest Developments
7.14 Hisun Pharmaceutical
7.14.1 Hisun Pharmaceutical Company Summary
7.14.2 Hisun Pharmaceutical Business Overview
7.14.3 Hisun Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.14.4 Hisun Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.14.5 Hisun Pharmaceutical Key News & Latest Developments
7.15 Luye Pharma
7.15.1 Luye Pharma Company Summary
7.15.2 Luye Pharma Business Overview
7.15.3 Luye Pharma Neurodegenerative Disease Major Product Offerings
7.15.4 Luye Pharma Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.15.5 Luye Pharma Key News & Latest Developments
7.16 Ark Pharmaceutical
7.16.1 Ark Pharmaceutical Company Summary
7.16.2 Ark Pharmaceutical Business Overview
7.16.3 Ark Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.16.4 Ark Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.16.5 Ark Pharmaceutical Key News & Latest Developments
7.17 Kanghong Pharmaceutical
7.17.1 Kanghong Pharmaceutical Company Summary
7.17.2 Kanghong Pharmaceutical Business Overview
7.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.17.4 Kanghong Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.17.5 Kanghong Pharmaceutical Key News & Latest Developments
7.18 Huahai Pharmaceutical
7.18.1 Huahai Pharmaceutical Company Summary
7.18.2 Huahai Pharmaceutical Business Overview
7.18.3 Huahai Pharmaceutical Neurodegenerative Disease Major Product Offerings
7.18.4 Huahai Pharmaceutical Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.18.5 Huahai Pharmaceutical Key News & Latest Developments
7.19 BORA PHARMACEUTICALS
7.19.1 BORA PHARMACEUTICALS Company Summary
7.19.2 BORA PHARMACEUTICALS Business Overview
7.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Major Product Offerings
7.19.4 BORA PHARMACEUTICALS Neurodegenerative Disease Revenue in Global Market (2019-2024)
7.19.5 BORA PHARMACEUTICALS Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
